Dobutamine

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
ANDA074086 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Dobutamine Injection, Usp Is Indicated When Parenteral Therapy Is Necessary For Inotropic Support In The Short-Term Treatment Of Adults With Cardiac Decompensation Due To Depressed Contractility Resulting Either From Organic Heart Disease Or From Cardiac Surgical Procedures. In Patients Who Have Atrial Fibrillation With Rapid Ventricular Response, A Digitalis Preparation Should Be Used Prior To Institution Of Therapy With Dobutamine Hydrochloride.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dobutamine Hydrochloride DOBUTAMINE HYDROCHLORIDE ZINC57278

Comments